The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol

When It Comes to HIV Treatment Success, More Pills, More Problems

February 4, 2014

How many pills do you take every day to treat your HIV? That number might have a significant impact on the success of your regimen. According to a new study published in the online edition of Clinical Infectious Diseases, having to take fewer pills daily significantly increases rates of adherence to HIV treatment and gives people better virological outcomes -- basically, lower viral loads. The authors of the study said:

Higher pill burden was associated with both lower adherence and worse virologic suppression in both twice-daily and once-daily subgroups. In addition, adherence was higher with once-daily ART [antiretroviral therapy] regimens than with twice-daily regimens. ... However, this difference was minimal and did not translate into better treatment outcomes.

The evolution of antiretrovirals is long and complicated, but with three once-a-day, single-pill regimens -- Atripla (efavirenz/tenofovir/FTC), Complera (rilpivirine/tenofovir/FTC) and Stribild (elvitegravir/cobicistat/FTC/tenofovir) -- now available, medications causing fewer side effects than before and simplified dosing schedules, HIV medications are making adherence easier than ever.

However, adherence can still be an issue for some people. If you are having troubles with adherence, please visit's Resource Center on Keeping Up With Your HIV Meds.

To read the full study summarized in this article, please visit the site for Clinical Infectious Diseases.

Mathew Rodriguez is the editorial project manager for and

Follow Mathew on Twitter: @mathewrodriguez.

Copyright © 2014 Remedy Health Media, LLC. All rights reserved.

Related Stories

Breaking the Silence on My Struggle With HIV Meds
Getting to Undetectable: People Living With HIV Share Their Stories
6 Reasons Why People Skip Their HIV Meds
Word on the Street: Advice on Adhering to HIV Treatment
More HIV Treatment Adherence Research

This article was provided by TheBody.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our advertising policy.